Prostate Cancer - Results from #1320

Extended Safety and Tolerability of Darolutamide for Nonmetastatic Castration-Resistant Prostate Cancer and Adverse Event Time Course in ARAMIS. February 27, 2024

Opportunistic Prostate Cancer Screening with Biparametric Magnetic Resonance Imaging (VISIONING). February 27, 2024

Variation in communication of side effects in prostate cancer treatment consultations. February 27, 2024

Lineage-specific canonical and non-canonical activity of EZH2 in advanced prostate cancer subtypes. February 27, 2024

Diffuse Pneumonitis after Lutetium-177-PSMA-617 Treatment in a Patient with Metastatic Castration-Resistant Prostate Cancer. February 27, 2024

Transperineal Versus Transrectal Magnetic Resonance Imaging-targeted Biopsies for Prostate Cancer Diagnosis: Final Results of the Randomized PERFECT trial (CCAFU-PR1). February 27, 2024

Updated 5-year results for short course abiraterone acetate and LHRH agonist for unfavorable intermediate and favorable high-risk prostate cancer. February 26, 2024

Prostate Cancer Detection Rate of Transperineal Prostate Biopsy: Cognitive Versus Software Fusion, A Multicenter Analysis. February 26, 2024

Prostate-specific membrane antigen-positron emission tomography (PSMA-PET) of prostate cancer: current and emerging applications. February 26, 2024

A longitudinal mixed-methods study of pathology explanation clinics in patients with newly diagnosed localized prostate cancer. February 26, 2024

Development of CD46 targeted alpha theranostics in prostate cancer using 134Ce/225Ac-Macropa-PEG4-YS5. February 26, 2024

A Proposal for the Comprehensive Care of Men on Androgen Deprivation Therapy: Recommendations From the Multidisciplinary Prostate Cancer 360 Working Group. February 23, 2024

Addressing controversial areas in the management of advanced prostate cancer in Canada: Areas of consensus and controversy from the third Canadian consensus forum. February 23, 2024

Inherited Mutations in DNA Damage Repair Genes in Italian Men with Metastatic Prostate Cancer: Results from the Meet-URO 10 Study. February 23, 2024

Incidence and survival of secondary malignancies after external beam radiotherapy for prostate cancer in the Surveillance, Epidemiology, and End Results database. February 23, 2024

Clinical implications of AR alterations in advanced prostate cancer: a multi-institutional collaboration. February 23, 2024

Risk of Fractures and Falls in Men with Advanced or Metastatic Prostate Cancer Receiving Androgen Deprivation Therapy and Treated with Novel Androgen Receptor Signalling Inhibitors: A Systematic Review and Meta-analysis of Randomised Controlled Trials. February 23, 2024

Reversibility of Bicalutamide PSMA PET-Positive Gynecomastia With Androgen Deprivation Therapy. February 22, 2024

Gold nanoshells for prostate cancer treatment: evidence for deposition in abdominal organs. February 22, 2024

Stereotactic ablative radiation therapy in metastatic prostate cancer. February 22, 2024

Page 67 of 1436